Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).
Ruers, T
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Oct 2012 - 2619-2626 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1569-8041
10.1093/annonc/mds053 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Colorectal Neoplasms--pathology
Female
Humans
Liver Neoplasms--drug therapy
Male
Middle Aged
Survival Rate
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Oct 2012 - 2619-2626 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1569-8041
10.1093/annonc/mds053 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Colorectal Neoplasms--pathology
Female
Humans
Liver Neoplasms--drug therapy
Male
Middle Aged
Survival Rate